On October 2, 2025 Kraig Biocraft Laboratories (OTCQB: KBLB) issued a press release announcing that it has achieved the first successful mass production of spider silk using its proprietary silkworm platform. The company’s genetically engineered silkworms now produce spider‑silk proteins as they spin, enabling scalable, cost‑effective, and sustainable production that had previously been impossible with traditional spider farming.
This milestone represents a breakthrough in the company’s core technology, solving a long‑standing challenge that has prevented spider silk from reaching commercial markets. By moving from laboratory‑scale experiments to commercial‑scale facilities, Kraig Labs is now positioned to supply high‑performance, eco‑friendly fibers to defense, medical, and apparel sectors.
The announcement underscores the company’s progress toward commercial deliveries and signals that its spider‑silk platform is ready for broader market adoption, potentially opening new revenue streams and strengthening its competitive position in the specialty fiber industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.